1. Home
  2. KD vs DVA Comparison

KD vs DVA Comparison

Compare KD & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KD
  • DVA
  • Stock Information
  • Founded
  • KD 2020
  • DVA 1994
  • Country
  • KD United States
  • DVA United States
  • Employees
  • KD N/A
  • DVA N/A
  • Industry
  • KD EDP Services
  • DVA Misc Health and Biotechnology Services
  • Sector
  • KD Technology
  • DVA Health Care
  • Exchange
  • KD Nasdaq
  • DVA Nasdaq
  • Market Cap
  • KD 9.6B
  • DVA 10.9B
  • IPO Year
  • KD N/A
  • DVA 1995
  • Fundamental
  • Price
  • KD $39.79
  • DVA $142.58
  • Analyst Decision
  • KD Strong Buy
  • DVA Hold
  • Analyst Count
  • KD 3
  • DVA 4
  • Target Price
  • KD $46.00
  • DVA $157.00
  • AVG Volume (30 Days)
  • KD 2.0M
  • DVA 873.0K
  • Earning Date
  • KD 07-30-2025
  • DVA 08-05-2025
  • Dividend Yield
  • KD N/A
  • DVA N/A
  • EPS Growth
  • KD N/A
  • DVA 14.90
  • EPS
  • KD 1.05
  • DVA 10.11
  • Revenue
  • KD $15,057,000,000.00
  • DVA $12,968,524,000.00
  • Revenue This Year
  • KD $6.40
  • DVA $6.46
  • Revenue Next Year
  • KD $2.51
  • DVA $3.24
  • P/E Ratio
  • KD $37.89
  • DVA $14.10
  • Revenue Growth
  • KD N/A
  • DVA 5.11
  • 52 Week Low
  • KD $21.34
  • DVA $131.76
  • 52 Week High
  • KD $44.20
  • DVA $179.60
  • Technical
  • Relative Strength Index (RSI)
  • KD 44.56
  • DVA 54.05
  • Support Level
  • KD $42.41
  • DVA $139.55
  • Resistance Level
  • KD $44.20
  • DVA $145.88
  • Average True Range (ATR)
  • KD 1.32
  • DVA 3.32
  • MACD
  • KD -0.21
  • DVA 0.29
  • Stochastic Oscillator
  • KD 28.87
  • DVA 60.43

About KD Kyndryl Holdings Inc.

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: